Relationship of -Blocker Dose with Outcomes in Ambulatory Heart Failure Patients with Systolic Dysfunction: Results from the HF-ACTION Trial

OBJECTIVES: To examine the association between baseline beta-blocker (BB) dose and outcomes in the HF-ACTION trial. BACKGROUND: BBs reduce morbidity and mortality in chronic heart failure (HF) patients with reduced ejection fraction, but it is unclear whether titrating to higher BB doses improves ou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fiuzat, Mona, Wojdyla, Daniel, Kitzman, Dalane, Fleg, Jerome, Keteyian, Steven J., Kraus, William E., Piña, Ileana L., Whellan, David, O’Connor, Christopher M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396733/
https://ncbi.nlm.nih.gov/pubmed/22560018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2012.03.023
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak